Search

Search Constraints

You searched for: Author/Creator Burger, Robert A

Search Results

1. 2022-RA-439-ESGO Up-next (ENGOT-Ov71-NSGO-CTU/GOG-3049): a study of upitifamab rilsodotin (UpRi), a napi2b-directed antibody drug conjugate (ADC) in platinum-sensitive recurrent ovarian cancer. (20th October 2022)

2. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Issue 10103 (7th October 2017)

3. Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment. Issue 7 (12th July 2019)

4. Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment. Issue 7 (September 2019)

5. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. (17th March 2021)